Veliparib (ABT-888) is a PARP inhibitor being investigated to treat non-small cell lung cancer, BRCA breast cancer and ovarian cancer.
Type of Molecule
Small Molecule
Target
PARP
Region
n/a
| Potential Indication | Product Type | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Breast Cancer | New Indication | Phase 3 |
| Lung Cancer | New Indication | Phase 3 |
| Ovarian Cancer | New Indication | Phase 3 |